Biktarvy, formally known as bictegravir sulfate, includes a powerful single-tablet therapy for treating HIV infection. This formula unites three key antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the virus's ability to replicate within the body, considerably reducing the viral burden. For many indi